MedTrace Logo

Comparison of The Success Rates of Four Different Pulpotomy Techniques

NCT03135626 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2017-05-01

No results posted yet for this study

Summary

This randomized clinical trial was conducted to examine and compare the effectiveness of pulpotomy in primary molars treated with calcium silicate based materials including Biodentine and two different mineral trioxide aggregate (MTA) products (white ProRoot® MTA and MTA Plus®). Ferric sulfate pulpotomy was selected to represent the control group. 116 primary molars in 29 children were treated by pulpotomy and followed for a period of 24 months.

Conditions

  • Extensive Decay in Primary Molars

Interventions

DRUG

Biodentine

DRUG

ProRoot (Aggregate)

DRUG

MTA Plus

DRUG

Ferric Sulfate 20 % Dental Gel

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Yeliz Guven, Dr. · Istanbul University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-15
Primary Completion
2014-01-15
Completion
2016-02-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03135626 on ClinicalTrials.gov